ArticleEuropean journal of obstetrics & gynecology and reproductive biology: X2026
A logistic regression model for predicting postoperative recurrence of cellular uterine leiomyoma.
Article in European journal of obstetrics & gynecology and reproductive biology: X, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The risk factors for the postoperative recurrence of cellular uterine leiomyoma (CUL) remain unclear.This study aimed to identify independent risk factors for recurrence and to develop a predictive model based on clinical characteristics to assess individual recurrence risk. Methods: This retrospective study included patients who underwent uterine myomectomy at Fujian Maternal and Child Health Hospital between January 1, 2012, and December 31, 2021, and were pathologically confirmed to have CUL. The 176 patients who met the inclusion criteria were grouped into two categories: the recurrence group (76 cases) and the non-recurrence group (100 cases). Univariate and multivariate logistic regression analyses were performed to identify the risk factors for postoperative recurrence, and a nomogram prediction model was built. Results: Patients were followed for a median of 4 years (range: 1.75-7.5 years), during which 76 patients (43.2%) experienced recurrence.Tumor number ≥ 2, body mass index (BMI) ≥ 24.0 kg/m², and concurrent endometriosis were significantly associated with recurrence ( Conclusion: Patients with CUL who have risk factors require close monitoring for postoperative recurrence. The developed nomogram model exhibited good predictive performance, thereby offering a reference for treatment choice and recurrence prediction.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.